DNAPrint Genomics Inc. To Acquire Ellipsis Biotherapeutics Corporation

SARASOTA, FL -- (MARKET WIRE) -- 11/15/2005 -- DNAPrint™ genomics, Inc. (OTC BB: DNAG), a developer of genomics-based products and services, today announced that it has entered into an agreement to acquire the clinical genomics and genotyping assets of Ellipsis Biotherapeutics Corporation (“Ellipsis”), a privately held drug and diagnostic discovery company based in Toronto, Canada.

MORE ON THIS TOPIC